|Status : Upcoming||Report Code : VRHC1010||Industry : Healthcare||Available Format :|
Diabetes mellitus is the group of chronic endocrine disorder due to insufficient level of insulin. Prolonged hyperglycemia (high blood sugar) can lead to severe complications including cardiovascular disease, kidney failure, diabetic retinopathy or nephropathy, and ulcers. Blood glucose monitoring systems are used for the testing of blood glucose level in the body. The global blood glucose monitoring system market is growing at significant rate due to increasing prevalence of diabetes. The market is expected to grow at the faster rate for continuous blood glucose monitoring products in the coming years due to increasing adoption of minimally invasive procedure.
Insight by Product
There are two types of blood glucose monitoring system, self-monitoring blood glucose systems and continuous monitoring blood glucose system. Of both the types the continuous monitoring blood glucose system market is expected to grow at the higher growth rate, due to increasing adoption of minimally invasive procedure.
Insight by Testing Site
On the basis of testing site, the blood glucose monitoring system market is segment into fingertip testing and alternate site testing. Fingertip testing is the most common technique used for measurement of blood glucose level. Fingertip testing segment has the larger share and is also expected to grow at the faster rate due to high reliability and accuracy of fingertip testing.
Insight by Application
The global blood glucose monitoring system market has also been segmented by application into type I, type II and gestational diabetes. Type I diabetes accounts for about 5 to 10 percent of the diabetes cases and type II accounts for approximately 90 percent of the diabetic cases. Many patients with type II diabetes are asymptomatic. The type II diabetes segment is estimated to have largest share in the market due to increasing incidence of type II diabetes and increasing innovative product launches with less invasive technologies. For instance, according to International Diabetes Federation (IDF) in 2017 approximately 352 million people were at risk of developing type II diabetes.
Insight by Patient Care Setting
The end-users of blood glucose monitoring system market are hospitals and clinics, and home care. The home care segment has the largest share and expected to grow at fastest rate due to increasing diabetic population, increasing innovative product launches enhancing patient comfort and increasing awareness of regular monitoring of glucose levels.
The increasing prevalence of diabetes, rapid increase in aging population and increasing number of product launches are the primary growth drivers for blood glucose monitoring system market. For instance, according to World Health Organization (WHO), the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Pipeline products and ongoing researches and increasing adoption of continuous sugar surveillance system are also driving the global market. The technological advancement in glucose monitoring is making device smaller and more convenient.
The high cost of blood glucose monitoring products, invasiveness of blood glucose monitors and poor reimbursement of blood glucose monitoring devices and supplies are the major challenges for the growth of blood glucose monitoring system market. In developing countries it is difficult to bear the cost of the testing strips and blood glucose monitors due to poor reimbursement policies. Moreover, in some of the developed countries in Europe and in Canada, the limitation on the supply of testing strips per patient hinder the growth of the market.
The strong distribution channel for blood glucose monitoring products helps to cater the increasing demand of diabetic care device. The key challenge for the new entrants is the survival in capital intensive and highly regulated blood glucose monitoring system market.
Geographically, North America is the largest blood glucose monitoring system market as the region has favorable reimbursement policies, increasing awareness program and rising FDA approvals. Increasing prevalence of diabetes has fueled the growth of the North American blood glucose monitoring system market. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015, approximately 23.1 million people in the U.S. had diabetes.
Asia-Pacific is observed to witness the fastest growth in demand for blood glucose monitoring products. Increasing prevalence of diabetes, increasing awareness of diabetes, increasing healthcare expenditure, and large population base are creating a positive impact on the blood glucose monitoring systems market growth in the region.
Key players in the blood glucose monitoring system market are investing in the development of innovative and advance products, which is strengthening their position in the market. In September 2016, Abbott gained FDA approval for the FreeStyle Libre Pro continuous glucose monitoring (CGM) device, a professional-use device to provide better diabetes management to diabetes patient. In addition, in August 2016, Roche launched the Accu-Chek Guide, the next-generation blood glucose monitoring system. Abbott Laboratories, B. Braun Melsungen, F. Hoffmann-La Roche, Ypsomed, Lifescan, Medtronic, Ascensia Diabetes Care, Dexcom, Nipro and Sanofi are the key players offering blood glucose monitoring products.